A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole

NCT01627587 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstetric Labour, Premature

Interventions

DRUG: GSK221149 750 mg
DRUG: Ketoconazole
DRUG: GSK221149 100 mg
DRUG: GSK221149 750 mg Fasted
DRUG: GSK221149 750 mg + Food

Sponsor

GlaxoSmithKline